Fly On Wall * Brean Capital Raises to $19 On CLDX Strong Data & Robust Pipelint. LINK
Fly On The Wall 6/12/13
June 12, 2013
CLDX Celldex price target raised to $19 from $14 at Brean Capital Brean Capital raised its price target on Celldex due to its strong clinical data and robust pipeline. Shares are Buy rated.